ORIGINAL RESEARCH article

Front. Cell. Neurosci., 01 May 2024

Sec. Cellular Neurophysiology

Volume 18 - 2024 | https://doi.org/10.3389/fncel.2024.1396387

Age-related upregulation of dense core vesicles in the central inferior colliculus

  • JG

    Jeffrey G. Mellott 1,2*

  • SD

    Syllissa Duncan 1

  • JB

    Justine Busby 1

  • LS

    Laila S. Almassri 1,2

  • AW

    Alexa Wawrzyniak 1

  • MC

    Milena C. Iafrate 1

  • AP

    Andrew P. Ohl 1

  • EA

    Elizabeth A. Slabinski 1

  • AM

    Abigail M. Beaver 1

  • DA

    Diana Albaba 1

  • BV

    Brenda Vega 1

  • AM

    Amir M. Mafi 3

  • MB

    Morgan Buerke 4

  • NJ

    Nick J. Tokar 1

  • JW

    Jesse W. Young 1

  • 1. Department of Anatomy and Neurobiology, Northeast Ohio Medical University, Rootstown, OH, United States

  • 2. University Hospitals Hearing Research Center, Northeast Ohio Medical University, Rootstown, OH, United States

  • 3. The Ohio State University College of Medicine, Columbus, OH, United States

  • 4. Department of Psychology, Louisiana State University, Baton Rouge, LA, United States

Abstract

Presbycusis is one of the most prevalent disabilities in aged populations of industrialized countries. As we age less excitation reaches the central auditory system from the periphery. To compensate, the central auditory system [e.g., the inferior colliculus (IC)], downregulates GABAergic inhibition to maintain homeostatic balance. However, the continued downregulation of GABA in the IC causes a disruption in temporal precision related to presbycusis. Many studies of age-related changes to neurotransmission in the IC have therefore focused on GABAergic systems. However, we have discovered that dense core vesicles (DCVs) are significantly upregulated with age in the IC. DCVs can carry neuropeptides, co-transmitters, neurotrophic factors, and proteins destined for the presynaptic zone to participate in synaptogenesis. We used immuno transmission electron microscopy across four age groups (3-month; 19-month; 24-month; and 28-month) of Fisher Brown Norway rats to examine the ultrastructure of DCVs in the IC. Tissue was stained post-embedding for GABA immunoreactivity. DCVs were characterized by diameter and by the neurochemical profile (GABAergic/non-GABAergic) of their location (bouton, axon, soma, and dendrite). Our data was collected across the dorsolateral to ventromedial axis of the central IC. After quantification, we had three primary findings. First, the age-related increase of DCVs occurred most robustly in non-GABAergic dendrites in the middle and low frequency regions of the central IC during middle age. Second, the likelihood of a bouton having more than one DCV increased with age. Lastly, although there was an age-related loss of terminals throughout the IC, the proportion of terminals that contained at least one DCV did not decline. We interpret this finding to mean that terminals carrying proteins packaged in DCVs are spared with age. Several recent studies have demonstrated a role for neuropeptides in the IC in defining cell types and regulating inhibitory and excitatory neurotransmission. Given the age-related increase of DCVs in the IC, it will be critical that future studies determine whether (1) specific neuropeptides are altered with age in the IC and (2) if these neuropeptides contribute to the loss of inhibition and/or increase of excitability that occurs during presbycusis and tinnitus.

1 Introduction

The auditory system plays a crucial role in our everyday lives by enabling communication, sound localization, and information processing. Conversely, auditory system dysfunction leads to impaired communication, difficulty participating in noisy social environments, and an overall decrease in quality of life. As the aging population continues to grow, there is an increased demand for understanding the mechanisms underlying hearing loss, which affects nearly three-quarters of individuals aged 70 years or older (). The functional decline of the auditory system with age often begins with the degradation of the peripheral auditory system, which leads to a decrease in excitation sent to the central auditory system (; ). The central auditory system compensates for this decreased excitation by downregulating GABAergic inhibition; this is believed to be an attempt at restoring homeostatic levels of activity (; ; ). Unfortunately the gradual loss of GABA into old age leads to functional deficits and increased central neural gain (; , ). Age-related downregulation of GABAergic inhibition is well documented in the inferior colliculus (IC), an auditory midbrain structure that serves as the hub of the central auditory system (; ; ). The IC is organized into three subdivisions [central (ICc), lateral cortex (IClc), and dorsal cortex (ICd)] and processes information from multiple ascending and descending auditory projections (see reviews: ; ). Neurons and inputs within the lemniscal ICc are arranged into isofrequency lamina, which are organized tonotopically along the ventromedial (high frequencies) to dorsolateral (low frequencies) axis (; ; ; ).

Considering that mammalian presbycusis is frequency specific, it is important to understand age-related molecular and ultrastructural changes in relation to the tonotopic axis (; ; ; ). In our ongoing investigations of the aging synaptic ultrastructure in the IC, we observed a dramatic increase of dense core vesicles (DCVs) in the aged IC. In the current study, we quantify and characterize this increase in DCVs. DCVs are membrane-bound organelles that contain dense granular cores; they are one of two types of organelles that secrete chemical signals throughout the nervous system, with classic clear synaptic vesicles being the other (; ). Unlike synaptic vesicles which are found in large pools at active zones and carry classic neurotransmitters, DCVs are rarer, and they tend to package biogenic amines, neuromodulators, presynaptic machinery, neuropeptides, neurotrophic factors, and hormones (; ; ; ). A number of important neuromodulators involved in auditory midbrain function are transported by DCVs, including serotonin, neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), brain-derived neurotrophic factor (BDNF), and fibroblast growth factors (; ; ; ; ; , ). DCVs are transported via both dendritic and axonal trafficking, where microtubule dependent kinesin-1 motors (KIF1) and motor dynein mediate trafficking into dendrites and axons (; ). It is unclear whether DCVs are preferentially released at axons or dendrites (; ). To our knowledge, very little is understood about the populations of DCVs in the auditory midbrain, including what proteins they contain and their trafficking patterns.

The goal of the present study is to determine whether DCVs are upregulated in the aging ICc. Specifically, we examined three tissue blocks taken across the ventromedial-dorsolateral ICc axis. For the sake of conciseness, alignment with our previous studies, and convention as the tonotopic axis is well established, we refer to the ventromedial-most ICc block as representing the high frequency region, the middle block as representing the middle frequency region, and dorsolateral-most block as representing lower frequencies. We used immuno transmission electron microscopy to analyze DCVs in GABAergic and non-GABAergic boutons, axons, and dendrites of Fischer Brown Norway (FBN) rats across four (3–4 months “young”; 19–20 months “early middle-age”; 24 months “late middle-age”; and 28–29 months “old”) age groups. We discovered that: (1) DCVs were markedly increased in non-GABAergic dendrites during middle age. Many of these DCVs were located near postsynaptic densities. (2) The probability of a GABAergic or non-GABAergic bouton having more than one DCV increased with age. (3) Despite the age-related loss of boutons throughout the IC, the percentage of non-GABAergic and GABAergic boutons that had at least one DCV did not decline with age. We conclude that synapses lost in the IC in aging may not be synapses that co-release neuropeptides. Ultimately, it appears that the many possible proteins packaged by DCVs may have a significant role in the processing of acoustic signals in the aging IC.

2 Materials and methods

2.1 Animals

All procedures were conducted in accordance with the Northeast Ohio Medical University Institutional Animal Care and Use Committee and NIH guidelines. Results are described from 20 male FBN rats [National Institute of Aging; Bethesda, MD, USA; RRID:SCR_007317 (housed by Charles River Laboratories, Wilmington, MA, USA)] across four age groups (5 animals per age group): 3–4 months “young”; 19–20 months “early middle-age”; 24 months “late middle-age”; and 28–29 months “old” (Tables 13). For a details regarding ambient sound levels, please see . Efforts were made to minimize the number of animals and their suffering.

TABLE 1

# of animalsArea analyzed (μm2)# of DCVAverage diameter (nm)# of DCV in bouton# of DCV in axon# of DCV in dendrite
3–4 month
High frequency516,000 (3,200/animal)17569.2751684
Middle frequency516,000 (3,200/animal)18466.2891183
Low frequency516,000 (3,200/animal)19469.21001381
19–20 month
High frequency516,000 (3,200/animal)35665.31629185
Middle frequency516,000 (3,200/animal)31169.711320188
Low frequency516,000 (3,200/animal)26770.511023142
24 month
High frequency516,000 (3,200/animal)43868.816227244
Middle frequency516,000 (3,200/animal)42871.116039225
Low frequency516,000 (3,200/animal)38270.913323226
28 month
High frequency516,000 (3,200/animal)39962.414724222
Middle frequency516,000 (3,200/animal)35165.214614190
Low frequency516,000 (3,200/animal)32664.713326165
Summary of ICc DCV in GABAergic profiles
3–4 month
High frequency516,000 (3,200/animal)8569.849924
Middle frequency516,000 (3,200/animal)11070.9421844
Low frequency516,000 (3,200/animal)9774.2621024
19–20 month
High frequency516,000 (3,200/animal)11065.364739
Middle frequency516,000 (3,200/animal)11671.665934
Low frequency516,000 (3,200/animal)10267.4501234
24 month
High frequency516,000 (3,200/animal)1637168982
Middle frequency516,000 (3,200/animal)16573.8861461
Low frequency516,000 (3,200/animal)14869.386950
28 month
High frequency516,000 (3,200/animal)18861.2761884
Middle frequency516,000 (3,200/animal)15868.289951
Low frequency516,000 (3,200/animal)12565.1531939

Summary of ICc DCV in GABA-negative profiles.

TABLE 2

Total boutonsBouton loss from 3 monthsTotal DCVs# of boutons w/1 DCV# of boutons w/2 DCV# of boutons w/3 DCV# of boutons w/4 DCV# of boutons w/5 DCV# of boutons w/>5 DCV# of boutons w/at least 1 DCV% boutons w/at least 1 DCV
3–4 months
High frequency
B72; R232241381110
B96; R412079527
B123; R4220210718
B129; R11619422123116
B132; R11724021104115
Total1,067N/A7542103100565.24%
Middle frequency
B73; R23208134318
B97; R412151210212
B124; R4221919111214
B130; R11618525133218
B133; R11720420141116
Total1,031N/A8952105100686.60%
Low frequency
B74; R232171713114
B98; R412258617
B125; R4219221101314
B131; R11623136213327
B134; R1172371874112
Total1,096N/A1005797100746.80%
19–20 months
High frequency
B78; R63184411554125
B81; R98197241511118
B84; R99204331433121
B105; R84187351642123
B142; R9620929143323
Total9819.10%16274161331011011.20%
Middle frequency
B79; R631862356213
B82; R9819619721111
B103; R8321839852318
B106; R84154555
B141; R962012715621
Total9557.40%11340195310687.12%
Low frequency
B80; R63202369441119
B86; R9920727542213
B104; R831792010515
B107; R84200116118
B143; R962211692112
Total1,0098%11039168310676.60%
24 months
High frequency
B111; R1011582353311
B114; R10215628942116
B117; R10017027114217
B135; R1091432562513
B138; R11018759166431 (7)29
Total81423.80%1624719118118611%
Middle frequency
B112; R10120225452112
B115; R1021795325222233
B118; R10013231522413
B121; R1081661910313
B136; R109137327251 (6)15
Total81620.90%1605111146318610.50%
Low frequency
B113; R10116719911112
B116; R102217471083324
B119; R1001767516
B122; R108203364451115
B137; R10916024123217
Total92315.80%133401711420748.02%
28–29 months
High frequency
B87; R29134126118
B90; R4615448567220
B93; R7914711819
B99; R451343377418
B126; R47181439912122
Total75029.70%1473523133307710.30%
Middle frequency
B88; R9915610628
B91; R46173295341 (6)13
B94; R791503613421121
B100; R451584244521 (7)16
B127; R4713829155121
Total77524.80%1464318114127910.20%
Low frequency
B89; R99167125218
B92; R461904411125120
B95; R79189341242220
B101; R4518027763117
B128; R471771614115
Total90317.60%13349148720808.70%

Excitatory bouton breakdown.

“BXX” designates the block number. “RXX” designates the animal.

TABLE 3

Total boutonsBouton loss from 3 monthsTotal DCVs# of boutons w/1 DCV# of boutons w/2 DCV# of boutons w/3 DCV# of boutons w/4 DCV# of boutons w/5 DCV# of boutons w/>5 DCV# of boutons w/at least 1 DCV% of boutons w/at least 1 DCV
3–4 months
High frequency
B72; R231888628
B96; R412166314
B123; R421807415
B129; R116212143418
B132; R1172191472110
Total1,015N/A492384000353.50%
Middle frequency
B73; R23187444
B97; R411707516
B124; R4215913516
B130; R1162081432117
B133; R117193444
Total917N/A422132100272.90%
Low frequency
B74; R2323810819
B98; R412048718
B125; R4216415101112
B131; R1161722111516
B134; R1172098617
Total987N/A624291000525.30%
19–20 months
High frequency
B78; R631552584315
B81; R98171136118
B84; R99201145319
B105; R84196777
B142; R962225112
Total9456.90%642686100414.30%
Middle frequency
B79; R632171381110
B82; R981878617
B103; R8315418102113
B106; R8415911819
B141; R96133155229
Total8507.30%653764100485.60%
Low frequency
B80; R6314010819
B86; R991681771311
B104; R831747325
B107; R8420312819
B143; R96210444
Total8959.30%503043100384.20%
24 months
High frequency
B111; R1011991310111
B114; R1021625314
B117; R1001297617
B135; R1091708516
B138; R11017235845118
Total83218%683267100465.50%
Middle frequency
B112; R1011241654211
B115; R10218724841114
B118; R1001441992213
B121; R10812711538
B136; R10914216101112
Total72421%8637145110588.01%
Low frequency
B113; R10117016111113
B116; R102139159312
B119; R100155164329
B122; R108181155510
B137; R10915624124117
Total80118.90%8641163100617.60%
28–29 months
High frequency
B87; R291358617
B90; R461721874112
B93; R791369617
B99; R451591582111
B126; R47165261121216
Total76724.40%763894200536.90%
Middle frequency
B88; R99138555
B91; R4613022722112
B94; R7912911718
B100; R45130221311116
B127; R47153298631 (6)18
Total68025.80%894096211598.70%
Low frequency
B89; R991689336
B92; R461427415
B95; R79144333
B101; R45159777
B128; R4718227481114
Total79519.50%5321112100354.40%

GABAergic bouton breakdown.

“BXX” designates the block number. “RXX” designates the animal.

2.2 Perfusion and sectioning

Each animal was deeply anesthetized with isoflurane and perfused transcardially with Tyrode’s solution, followed by 250 ml of 2% glutaraldehyde and 2% paraformaldehyde [with one exception; case R79, Blocks 93,94, and 95 (Tables 1, 2) was perfused and stored with 3% glutaraldehyde and 1% paraformaldehyde] in 0.1 M phosphate buffer at a pH 7.4. The brain was removed and stored at 4°C in 2% glutaraldehyde and 2% paraformaldehyde in 0.1 M phosphate buffer. The following day the brain was prepared for processing by removing the cerebellum and cortex and blocking the remaining piece with transverse cuts posterior to the cochlear nucleus and anterior to the thalamus. The tissue was then cut into 50 μm thick transverse section with a Vibratome (VT1000S, Leica Microsystems, Buffalo Grove, IL, USA). The tissue was collected in six series. Series were processed as described below or stored in freezing buffer for future processing.

2.3 Tissue processing for EM

A series of tissue was post-fixed in 1% osmium tetroxide for 30 min, dehydrated in a series of alcohols (50%, 70%, 95%, 100% and 2× propylene oxide; each run was 10 min), embedded in Durcupan resin (Sigma-Aldrich; Millipore Sigma, Burlington, MA, USA) and flat-mounted between sheets of Aclar Embedding Film (Ted Pella, Inc., Redding, CA, USA) at 60°C for 48–72 h. Mid-rostrocaudal IC sections (between interaural levels 0.24 and 0.36 mm; ) were examined with brightfield stereomicroscopy. Trapezoidal blocks, with a 0.75 mm base and 0.5–0.6 mm height, were extracted across the ventromedial-dorsolateral axis of the ICc (Figure 1). Three “blocks” of tissue were taken from each animal processed in the study. The ventromedial-dorsomedial axis of the rat ICc, after fixation, is approximately 2 mm. To better avoid our dorsolateral-most block including lateral or dorsal cortex of the IC, the total length of tissue taken across the axis was ∼1.8 mm (0.6 mm height per block). Initial borders of the ICc were delineated according to the rat anatomical atlas of the brain (). Osmium fixation revealing the conspicuous lateral lemniscal fibers, libraries of decarboxylase (GAD) immunoreactivity in EM prepared tissue, adjacent sections reacted for Nissl, and our experience with EM in the IC further guided our block trimming to best ensure tissue was from ICc (; ; ). More specific details on the trimming process can be found in . Tissue blocks were glued to a cylindric resin base with cyanoacrylate (Krazy Glue, Columbus, OH, USA). IC sections with removed tissue blocks were then imaged for record keeping and representative comparison between cases. We refer to the ventromedial-most ICc block as representing the high frequency region, the middle-most block representing the middle frequency region, and dorsolateral-most block representing lower frequencies (Figure 1). We did not record from the ICc; however we adopt this naming convention for the sake of conciseness, brevity, and convention as the tonotopic axis is well established.

FIGURE 1

Ultrathin sections were taken at a thickness of 50 nm with an ultramicrotome (UC6 Ultramicrotome, Leica Microsystems, Buffalo Grove, IL, USA). For each block of tissue, every twelfth section was collected onto a 200 or 300-mesh Formvar coated nickel mesh grid (Electron Microscopy Science, Hatfield, PA, USA) to ensure a singular synapse was not collected across two grids and analyzed twice. A total of eight grids, each with a single ultrathin section of layer of the ICc, were collected per block of tissue. Briefly, see and , sections dried for 3 h and were then placed overnight into anti-GABA antibody (rabbit anti-GABA, Sigma, St. Louis, MO, USA) diluted 1:500 in 0.05 M Tris-buffered saline with 0.1% Triton X-100, pH 7.6 (TBST), washed in TBST pH 7.6, then washed in TBST pH 8.2, and placed into a secondary antibody conjugated to 15 nm gold particles (goat anti-rabbit, diluted 1:25 in TBST pH 8.2; Ted Pella Inc., Redding, CA, USA). Lastly, sections were washed in TBST pH 7.6, washed in Nanopure water, stained with uranyl acetate (2% aqueous) and Reynold’s lead citrate (), and dried.

2.4 EM imaging

Sixty blocks of tissue from 20 male FBN rats with superior ultrastructure were chosen for imaging and quantification. We use a 5-point scale to grade the intactness and quality of ultrastructure in each case. Only tissue with a score of 4 or 5 was quantified. Our 5-point scale reflects a combination of successful fixation, immunogold processing and absence of electron dense artifacts. Nine of the 15 cases were scored as a “5” and the remaining six cases were a “4.” Scores of 4 and 5 yield clear ultrastructure with easily identifiable profiles that are readily resolved. The distinction between a 4 and a 5 is commonly due to a fold in the tissue or excess precipitate, which we avoid when imaging. Tissue scored as a 3 yields ultrastructure that can be qualitatively analyzed; however membrane integrity is not preserved such that quantitative data can be consistently extracted. All images presented are from a case scored as a 4/5. Tissue scored as a 1 or 2 has severe defects in the pre- and postsynaptic membranes such that synaptic profiles are difficult to interpret. Ultrastructure of the ICc was imaged with a transmission electron microscope (JEM-1400Plus, JEOL, Peabody, MA, USA) at an accelerating voltage of 80 kV and at a magnification of 50,000. Based on experience, a magnification of 50,000 ensures that all inhibitory synapses in the inferior colliculus are visible. Tissue was digitally imaged and rendered with an Orius 100 keV or Rio9 side mount camera (Gatan, Pleasanton, CA, USA). Images of ultrastructure were taken with Gatan Microscopy Suite Software (GMS3, Gatan, Pleasanton, CA, USA) integrated and calibrated with SerialEM Tomography software (). SerialEM is a gold standard for analytical applications in biological TEM and allowed us to image and analyze and add data at higher rate of efficiency. For each tissue block, we collected 400 μm2 (22,214 × 22,214 pixels) montages across 8 grids for a total of 3,200 μm2. All attempts were made such that each montage was collected from the center of each ultrathin section. Montages were analyzed by individuals blind to the age and ICc region imaged. Adobe Photoshop (Adobe Systems, Inc., San Jose, CA, USA) was used to add scale bars, crop images, adjust intensity levels and colorize monochrome images.

2.5 Analysis of inhibitory and excitatory profiles

We recorded each DCV that was present in a bouton, axon, and dendrite. Our classification of ultrastructure is largely based on the criteria defined by and our previous work (; ; ). Briefly, boutons have a “pool” of vesicles with clear centers and generally an absence of a cytoskeleton. We never observed a bouton with a DCV without clear vesicles. Dendrites were identified through a combination of criteria (irregular contours, spines, presence of synaptic inputs, and free ribosomes). Axons were commonly myelinated, and axons do not commonly contain free ribosomes in their cytoplasm. Identifying small unmyelinated axons from small dendrites provides some difficulty (). Generally speaking, small axons in the IC travel as bundles through the neuropil while dendrites travel in irregular patterns and are not typically in bundles. Additionally, the presence of ribosomes can help identify dendrites. When identifying a presynaptic terminal with a DCV we first note if the postsynaptic density is symmetric or asymmetric. We then classified each profile (bouton, axon, and dendrite) as non-GABAergic or GABAergic based on the accumulation of gold particles as compared to background (; ; ). In our previous report on the aging ultrastructure of the IC, we found that immunogold labeling was reduced in the aged tissue (). To maintain consistency between studies, older structures that were characterized as GABAergic had to have a density of gold particles that was at least three times greater than background. Although the goal of the current study was not synaptic analysis, when a DCV was identified in a bouton forming a synapse, we characterized the synapse as either excitatory or GABAergic for qualitative analysis. Synapses were classified by: (1) vesicle shape [pleomorphic vesicles (inhibitory) or round vesicles (excitatory)] and, (2) postsynaptic densities forming symmetric (pre- and postsynaptic membranes were of similar thickness; inhibitory) or asymmetric (postsynaptic densities were conspicuously thicker than the presynaptic densities; excitatory) junctions (; ; ; ). Detailed descriptions characterizing IC ultrastructure with post-embedding immunogold techniques to label GABAergic profiles can be found in and .

2.6 Data analysis

We examined 48,000 μm2 of ICc across five blocks of 3–4-month-old tissue, 48,000 μm2 of ICc across five blocks of 19–20-month-old tissue, 48,000 μm2 of ICc across five blocks of 24-month-old tissue, and 48,000 μm2 of ICc across five blocks of 28–29-month-old tissue with ImageJ (; Table 1). As boutons and synapses are known to be reduced in the aging IC, we quantified each bouton in each tissue block of each case to better understand age-related changes to the presence of DCVs in boutons (; ).

Variation in number of DCVs by ultrastructural location according to age group, was analyzed using one-way analysis of variance (ANOVA) models for each region. Six separate ANOVAs were run with age as the independent variable and number of DCVs as the outcome. Tukey’s Honest Significant Difference (HSD) was run for pairwise post-hoc tests of differences between consecutive age groups (i.e., 3–4 months versus 19–20 months, 19–20 months versus 24 months, 24 months versus 28–29 months) and pairwise values were adjusted using the false discovery rate procedure (), a method that simultaneously limits experiment-wise alpha inflation and minimizes the correlated loss of statistical power. All statistical tests were performed in R (version 3.6.3 for Mac OS X; ), supplemented by the add-on packages nlme compareGroups ().

3 Results

We examined the ultrastructural location of DCVs in non-GABAergic and GABAergic terminals, axons, and dendrites across four age groups (3–4 months, 19–20 months, 24 months, and 28–29 months) in the central inferior colliculus (ICc). We analyzed 3,811 DCVs in excitatory profiles and 1,567 DCVs in inhibitory profiles across 192,000 μm2 of tissue (Table 1). DCVs were most commonly located in non-GABAergic profiles at each age (Table 1). The most robust age-related increases of DCVs also occurred in non-GABAergic profiles (Table 1). We first describe DCV ultrastructure across the ventromedial-dorsolateral axis of the ICc. We then present data regarding age-related increases of DCVs in the dendrites of IC cells. Lastly, we qualitatively describe the frequency of DCVs in non-GABAergic and GABAergic boutons in the aging IC.

3.1 DCVs can be found across the ICc, regardless of age

Regardless of age and ventromedial-dorsolateral location, DCVs were found in dendrites, terminals, and axons in the ICc (Figure 2). We observed DCVs in both GABAergic and non-GABAergic presynaptic terminals in the ICc (Figures 2A, C, H, J–L). DCVs were also found in GABAergic and non-GABAergic dendrites (Figures 2D–G, I). Often, DCVs located in dendrites were near the postsynaptic density (Figures 2D, F, G, I). We did not observe DCVs at dendrodendritic synapses; it appears that dendrodendritic synapses in the rat IC are rare. At 28–29 months DCVs were found in presynaptic terminals forming non-prototypical synapses [e.g., GABAergic synapse forming an apparent asymmetric synapse (Figure 2J), non-GABAergic synapse with a subsynaptic body (Figure 2L)]. However, it was rare to observe a DCV bound to the pre- or postsynaptic membrane (Figure 2).

FIGURE 2

3.2 DCVs increase with age in non-GABAergic dendrites in low- and middle-frequency areas of the ICc

The total number of DCVs in non-GABAergic dendrites at 3–4 months across the high (ventromedial), middle and low (dorsolateral) frequency regions was 84, 83, and 81, respectively (Table 1). By 19–20 months these values doubled across the IC and increased further at 24 months (Table 1). When DCVs were observed in dendrites, they were typically singular and not near other DCVs. However at older ages in the low and middle frequency regions, while still uncommon, we observed DCVs near each other (Figure 3). In the low frequency region, the number of DCVs significantly increased from 83 to 226 at 24 months (*p = 0.004; Figure 4A). In the middle frequency region, the number of DCVs significantly increased from 83 to 255 at 24 months (*p = 0.025; Figure 4A). However the age-related increase of DCVs was not found to be significant at 19–20 months and 28–29 months (Figure 4A). In the high frequency region, despite an increase in the number of DCVs with age, our models did not detect a significant increase with age (Figure 4A).

FIGURE 3

FIGURE 4

3.3 DCVs do not significantly increase with age in GABAergic dendrites in the ICc

Although the total raw number of DCVs increased at older ages in the GABAergic dendrites, we found no significant change from 3 to 4 months in the high frequency region, middle frequency region and low frequency region (Figure 4B). A contributing factor to the non-significant findings appears to be the variability of DCV pools in the aging GABAergic dendrites. During aging we observed a few aged GABAergic dendrites in cross-section with dozens of DCVs (Figure 5). Thus, it appears that a few select neurons in the ICc may retrogradely transport neurotrophins and/or neuropeptides at great quantities during aging.

FIGURE 5

3.4 Non-GABAergic boutons with DCVs are more likely to be spared in aging

Approximately 6% of non-GABAergic boutons had one or more DCVs at 3–4 months of age (Table 2). The majority of these boutons had just one DCV, regardless of location in the ICc (Figure 6 and Table 2). At later ages, it became more common to find non-GABAergic boutons with at least one DCV, and boutons with multiple DCVs also increased (Figures 6, 7 and Table 2). These boutons with multiple DCVs commonly made synapses onto non-GABAergic dendrites (Figure 7). The most conspicuous increase of DCVs occurred in the high frequency ICc at 19–20 months, and the high and middle frequency regions at 24 months (Figure 6 and Table 2). At 3–4 months of age, the low frequency ICc had the greatest raw number (100) of DCVs (Table 2). However, by 19–20 months the number of DCVs in the high frequency/ventromedial region had more than doubled (75–162), and the percentage of non-GABAergic boutons with at least one DCV increased from 5.24% to 11.2% (Table 2). At 24 months, the number of DCVs in the middle frequency region of the ICc doubled (68–160), and the percentage of boutons with at least one DCV increased from 6.6% to 10.5% (Table 2). Increases in the number of DCVs in the low frequency region were less robust between 3–4 months and 24/28–29 months (100–133), and the percentage of boutons having at least one DCV between 3–4 months and 28 months increased slightly (6.8%–8.7%; Table 2). Overall, these increases were largely driven by an increasing population of non-GABAergic boutons having four or more DCVs (Figure 7 and Table 2).

FIGURE 6

FIGURE 7

As boutons and synapses are known to be downregulated in the aging IC, we quantified each non-GABAergic bouton in our experiments to better understand what proportion of boutons contain DCVs during aging. At 3–4 months we found a consistent number of boutons across the ventromedial-dorsolateral axis of the ICc (high-1,067; middle-1,031; low-1,096: Table 2). In the high frequency region at 19–20 month, 24 months, and 28–29 months there was a 9.1%, 23.8%, and 29.7% reduction of non-GABAergic boutons, respectively (Table 2). In the middle frequency region at 19–20 months, 24 months, and 28–29 months there was a 7.4%, 20.9%, and 24.8% reduction of non-GABAergic boutons, respectively (Table 2). Lastly, in the low frequency region at 19–20 months, 24 months, and 28–29 months there was a 8.0%, 15.8%, and 17.6% reduction of non-GABAergic boutons, respectively (Table 2). Taken together with the data mentioned above, our findings suggest that non-GABAergic cells/boutons that package DCVs are more likely to be spared during aging than non-GABAergic cells/boutons that do not package DCVs.

3.5 GABAergic boutons with DCVs are more likely to be spared in aging

Similar to non-GABAergic boutons, at any age and/or ICc location GABAergic boutons that contained DCVs typically had just one (Figure 8). GABAergic boutons with multiple DCVs occurred more routinely during aging in the middle and low frequency regions (Figure 8). However, at older ages, the proportion of GABAergic boutons with just one DCV increased in the high frequency ICc (Figure 8). As with the non-GABAergic population, during aging there was a greater raw number of DCVs in GABAergic boutons and a higher number of GABAergic boutons with at least one DCV in the high and middle frequency regions of the ICc (Figure 8 and Table 3). The raw number of DCVs in GABAergic boutons and number of GABAergic boutons with at least one DCV peaked at 24 months, but was lowest at 28 months (Figure 8 and Table 3).

FIGURE 8

We also quantified each GABAergic bouton in our experiments. Unsurprisingly, there was an overall reduction of GABAergic boutons at each age and at each ICc region (Table 3). The percentage of GABAergic boutons across the ICc with a DCV was only ∼4% at 3–4 months and increased during aging, with greater variability in the low frequency ICc (Table 3). Taken together we come to the same conclusion as we have with the non-GABAergic population: GABAergic cells/boutons that package DCVs are more likely to be spared during aging than GABAergic cells/boutons that do not package DCVs.

4 Discussion

The current study describes populations of DCVs in the aging ICc. Our findings demonstrate that DCVs are infrequent in the young rat ICc. This agrees with studies conducted in cat (). However, our data demonstrate that DCVs increase with aging in the rat ICc. Specifically we found the greatest increase of DCVs at 24 months in non-GABAergic dendrites throughout the middle and dorsolateral portions of the ICc’s ventromedial-dorsolateral tonotopic axis (corresponding to mid- and low-frequency representation). This is interesting as the FBN rat has been shown to lose low frequency hearing around 24 months of age (; ; ). While the raw number of DCVs in boutons did not significantly change during aging, there was (1) an increase in the number of boutons with multiple DCVs, and (2) the percentage of all boutons that had at least one DCV increased with age. Given that we broadly found a ∼25% loss of boutons across the ICc, which reflects findings by , we interpret our data to imply that presynaptic boutons in the ICc which are lost with age are not likely releasing contents that would be packaged by a DCV. As this is the first report of age-related changes to DCVs in the IC, future studies will hopefully determine what neuropeptides, neurotrophins and/or presynaptic proteins are undergoing age-related changes in the IC.

4.1 Technical considerations

The FBN rat is a recommended aging model by the National Institute on Aging as it has a longer median lifespan than other strains of mice and rats (; ). Of note, the FBN rat is routinely used as a characterized model for aging, in particular for studies of the central auditory system (; ; ; ; , , ; ). We have chosen to use four age groups in this study. Our 3–4 month and 28–29 month groups are standard ages for “young” and “old,” when there are no hearing deficits and very well characterized hearing loss, respectively. The use of two middle ages, a 19–20 month group and 24 month group, reflect ages when hearing deficits are not commonly reported and when hearing thresholds are significantly elevated, respectively (). However, we acknowledge that the hearing thresholds of the FBN rats in the current study were not measured and we do not know if a 19 month old rat had perfect hearing or if a 24 month old rat had poor hearing.

In the current study we equate parts of the ICc with tonotopic regions (e.g., low-frequency region). We did not characterize IC cells with electrophysiological techniques in the current study. We took the ventromedial-dorsomedial axis of the ICc tissue and divided it into thirds. While we do not know the characteristic frequencies represented in each tissue block, as the tonotopic axis of the IC is well established, we have no reason to believe that our ventromedial most block does not represent higher frequencies compared to the other two blocks; and the dorsolateral most block would represent the lowest frequencies. Another consideration in the interpretation of our data is that, although a common view of the IC’s tonotopic map is one of a continuous gradient, the rat IC tonotopic map may be organized in a stepwise manner (). Thus, our middle-most ICc blocks may represent frequencies closer to one end of the tonotopic map than the other.

We only immunolabeled for GABA, thus we cannot know the neurochemical profile of boutons that were not GABAergic. In terms of non-GABAergic boutons that formed symmetric synapses, we presume these are in part glycinergic. That said, the IC receives input from many neuromodulators, and the morphology of their postsynaptic densities are not well classified (). We hope that this study will serve as a foundation to examine the ultrastructure of neuromodulators and neurotransmitters that are packaged by DCVs in the aging IC.

4.2 DCVs in the inferior colliculus

The first ultrastructural description of DCVs in the IC was in cat (; ; ). Decades later, boutons containing DCVs were characterized in greater detail and defined a unique type of ICc bouton (). The current study broadly agrees with the findings from these original studies: (1) DCVs occurred in boutons with pools of smaller clear vesicles, (2) DCVs were not clustered toward the synapse or membrane, (3) boutons with DCVs commonly had 0–1 mitochondria, (4) DCVs are not uniformly found throughout the ICc, and (5) DCVs are generally uncommon in the ICc (). Our findings are further in line with in that we found presynaptic terminals with a DCV(s) terminating on a soma to be exceedingly rare (observed only once in our analysis of 192,000 μm2 of tissue). However, found that boutons carrying DCVs more routinely terminate on cell bodies.

The current study (in rat) differs from the previous studies (in cat) in two ways. First, work in the cat has demonstrated that when DCVs are present in presynaptic boutons, there may be over one to two dozen (; ). The current study in rats, and mice (unpublished observations), rarely revealed more than three DCVs in a single bouton. Previous reports of the rat IC ultrastructure also imply that DCVs, let alone pools of them, are rare (; ). Even though Roberts and Ribak revealed and described the rat IC ultrastructure in considerable detail, only one DCV is visible throughout their images (; ). Our data also appears to be in agreement with prior studies in rat hippocampus that quantified DCVs, as presynaptic terminals containing DCVs commonly had only a few (; ). Taken together, we believe that the pool size of DCVs in presynaptic terminals is likely species dependent.

Second, we found that the number of DCVs found in dendrites was nearly equal to the number of DCVs found in axons/boutons at young age (Table 1). Furthermore, specifically during middle-age in the dorsolateral half of the ICc, there was a significant age-related increase of DCVs in the ICc dendrites. Previous reports focus on DCVs pools in the IC do not describe a consistent population of DCVs throughout the dendrites of the ICc (; ). It is unknown if these reports simply did not analyze dendrites for DCVs or if there is a species difference between cats and the current studies that largely utilize rodent and cell culture. However, in the mammalian central nervous system, DCVs pools can be found equally distributed between the dendrites and axons/terminals of a given cell (). However, DCVs in the axons and boutons are often focused on as their release probability is much higher than the ones in the dendrites (Persoon, et al., 2018). It is important to note DCV fusion events in dendrites are not as tightly time locked to a cell firing and require sustained Ca2+ (). Fusion mechanism aside, dendritic exocytosis is a critical function for retrograde signaling, synapse growth and plasticity, and cellular morphology and DCVs play a prominent role in the dendritic release of many neuropeptides and neurotrophins (; ; ).

A major finding of the current study was that while there was a loss (∼25%) of boutons at old age, the percentage of boutons with DCVs did not change with age. Similar to the dendritic population, the more robust increases occurred in the GABA-negative boutons. We found that non-GABAergic and GABAergic boutons with DCVs made synapses onto both GABAergic and excitatory dendrites (we presume non-GABAergic dendrites in the IC are excitatory as only GABAergic and glutamatergic cells have been demonstrated in the IC, ; ) at any age. Thus, the contents of DCVs in the aging IC are likely affecting both inhibitory and excitatory circuits.

4.3 Functional implications

Broadly, DCVs are divided into small (∼40–80 nm) and large (∼90–200 nm) groups (; ; ; ; ; ; ). Smaller DCVs tend to package biogenic amines, neuromodulators, and presynaptic machinery, while larger DCVs tend to package neuropeptides, hormones and neurotrophic factors (; ; ; ). The exact diameter that defines a small versus a large DCV appears to be a sliding scale based on location (peripheral or central nervous system) and species, and what ultimately determines the size of a DCV is not well known (; ). Regardless of diameter, there appears to be considerable differences in the locations, releasing mechanisms, stimulation rates for release, and packaged content of DCVs between the peripheral and central nervous systems, nuclei within in the central nervous system, and between cultured and in vivo studies (; ; ). In the central nervous system, much of our knowledge regarding DCVs is obtained from the hippocampus, hypothalamus, and neuromodulatory nuclei (e.g. Raphe and Locus Coeruleus: ; ). As this is the first report on the aging DCV population in the IC, further studies are needed to reveal the functional relevance of our data. That said, we would like to comment on a few functions that an age-related increase of DCVs may reflect.

4.3.1 Hearing loss and neuromodulation

GABAergic inhibition is reduced in the aging IC (; ). This downregulation of GABA may be a compensatory homeostatic response to the loss of peripheral excitation (; ; ). Later in life the ongoing decline in GABAergic neurotransmission likely contributes to disrupted temporal precision and increases in central gain that underlie conditions such as presbycusis, tinnitus, and hyperacusis (; ; ; ; ; ; ).

Although a number of neuromodulators are released in the IC (e.g., serotonin, dopamine, acetylcholine, and noradrenaline), their roles in the aging IC across middle and old ages have not been thoroughly explored (; ; ; ; ; ; , ). In the context of the current study, serotonin neurotransmission may be a promising avenue to pursue in future studies. First, serotonin is known to be packaged in DCVs in the central nervous system (; ; ). Second, serotonin has a myriad of functions in the IC (, ; ; ). Third, it is known that aging and hearing loss affects serotonergic neurotransmission (; ; ). It is notable that in each of these studies, serotonin and its receptors increased in the aging IC and during hearing loss. Perhaps the increase of DCVs is correlated with increases of serotonin neurotransmission in the aging IC.

Recent studies in the IC have identified a novel class of GABAergic cells that express the neuropeptide/neuromodulator NPY (, ; ). Generally speaking, NPY in the brain provides neuroprotective effects during healthy and pathological aging (; ). Interestingly, NPY can be trafficked down dendrites, released postsynaptically, and act on presynaptic and postsynaptic receptors (; ). Future studies will use immunoEM to determine if NPY is also trafficked by DCVs in the dendrites of GABAergic IC cells. Given that NPY significantly regulates local excitation in the IC, it will be critical to determine how the balance of excitation and inhibition is affected by NPY neurotransmission in the aging IC. Our data show increased DCVs in middle and low frequency IC in a model of presbycusis, so it will be interesting to determine whether serotonin or NPY effects change across the tonotopic axis.

4.3.2 Brain-derived growth factor and plasticity

Another potential peptide contained in IC DCVs is BDNF, a neurotrophin released by DCVs throughout the brain to regulate functions such as synaptic transmission, plasticity, neurite growth, and gene regulation (; ). In the auditory system, BDNF is critical for development and normal acoustic function (; ; ). In the IC, BDNF has been tied to development, acoustic trauma, and dendritic integrity (; ; ; ). Further studies will need to determine if BDNF DCVs are trafficked to IC axons, dendrites or both as the cellular location of BDNF DCVs differ across reports (; ; ; ; ).

Fibroblast growth factors are another likely protein packaged by IC DCVs. Compellingly, levels of fibroblast growth factor receptor 2 (FGF-2) spike during middle age when hearing deficits are not common, and while there is a decrease at old age, FGF-2 levels are still elevated compared to young brains (). This pattern is very similar to trends in the current study, where DCVs in excitatory dendrites maximally increase at middle age and then decline into old age, yet are still more numerous than at young age. Given that (1) FGF-2 contributes to dendritic arborization and synaptic plasticity, (2) DCVs often carry contents such growth factors that play a role in synaptogenesis, and (3) the aged IC has a loss of dendrites and synapses, the IC may undergo a number of plastic events during middle age (; ; ). Further supporting the theory of increased plasticity with aging in the IC, perineuronal nets (organized extracellular matrix that have substantial roles in neural plasticity) increase with aging in the IC (; ; , ; ). Taken altogether, the increase of DCVs in the aging IC may contribute to elements of dendritic and synaptic plasticity.

Statements

Data availability statement

The original contributions presented in this study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics statement

The animal study was approved by the Northeast Ohio Medical University Institutional Animal Care and Use Committee. The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

JM: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. SD: Data curation, Formal analysis, Investigation, Writing – review & editing. JB: Data curation, Formal analysis, Investigation, Writing – review & editing. LA: Writing – original draft, Writing – review & editing. AW: Data curation, Formal analysis, Investigation, Supervision, Writing – review & editing. MI: Formal analysis, Investigation, Writing – review & editing. AO: Investigation, Methodology, Supervision, Writing – review & editing. ES: Data curation, Formal analysis, Investigation, Writing – review & editing. AB: Data curation, Investigation, Writing – review & editing. DA: Data curation, Investigation, Writing – review & editing. BV: Data curation, Investigation, Writing – review & editing. AM: Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing. MB: Data curation, Formal analysis, Investigation, Methodology, Software, Writing – review & editing. NT: Investigation, Project administration, Supervision, Writing – review & editing. JY: Data curation, Formal analysis, Software, Supervision, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the NIH/NIDCD grant R01 DC017708 and National Institute on Aging rodent colony.

Acknowledgments

We gratefully acknowledge Dr. Nichole Beebe for critical feedback on an earlier draft of the manuscript.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Abbreviations

DCV, dense core vesicle; FBN, Fischer Brown Norway; GABA, gamma-aminobutyric acid; GAD, glutamic acid decarboxylase; IC, inferior colliculus; ICc, central nucleus of the inferior colliculus; ICd, dorsal cortex of the inferior colliculus; IClc, lateral cortex of the inferior colliculus; LD, large dendrite; MD, medium dendrite; SD, small dendrite.

References

  • 1

    AlmassriL. S.OhlA. P.IafrateM. C.WadeA. D.TokarN. J.MafiA. M.et al (2023). Age-related upregulation of perineuronal nets on inferior collicular cells that project to the cochlear nucleus.Front. Aging Neurosci.15:1271008. 10.3389/fnagi.2023.1271008

  • 2

    AnairJ. D.SilveiraM. A.MirjaliliP.BeebeN. L.SchofieldB. R.RobertsM. T. (2022). Inhibitory NPY neurons provide a large and heterotopic commissural projection in the inferior colliculus.Front. Neural Circ.16:871924. 10.3389/fncir.2022.871924

  • 3

    AuerbachB. D.RadziwonK.SalviR. (2019). Testing the central gain model: Loudness growth correlates with central auditory gain enhancement in a rodent model of hyperacusis.Neuroscience40793107. 10.1016/j.neuroscience.2018.09.036

  • 4

    AuerbachB. D.RodriguesP. V.SalviR. J. (2014). Central gain control in tinnitus and hyperacusis.Front. Neurol.5:206. 10.3389/fneur.2014.00206

  • 5

    BenjaminiY.HochbergY. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing.J. R. Stat. Soc. Ser. B57289300.

  • 6

    BosiackiM.Gąssowska-DobrowolskaM.KojderK.FabiańskaM.JeżewskiD.GutowskaI.et al (2019). Perineuronal nets and their role in synaptic homeostasis.Int. J. Mol. Sci.20:4108.10.3390/ijms20174108

  • 7

    BrozoskiT. J.BauerC. A.CasparyD. M. (2002). Elevated fusiform cell activity in the dorsal cochlear nucleus of chinchillas with psychophysical evidence of tinnitus.J. Neurosci.2223832390.

  • 8

    BrunsD.RiedelD.KlingaufJ.JahnR. (2000). Quantal release of serotonin.Neuron28205220. 10.1016/s0896-6273(00)00097-0

  • 9

    CaiR.MontgomeryS. C.GravesK. A.CasparyD. M.CoxB. C. (2018). The FBN rat model of aging: Investigation of ABR waveforms and ribbon synapse changes.Neurobiol. Aging625363.

  • 10

    CasparyD. M.LingL.TurnerJ. G.HughesL. F. (2008). Inhibitory neurotransmission, plasticity and aging in the mammalian central auditory system.J. Exp. Biol.21117811791.

  • 11

    CasparyD. M.LlanoD. A. (2018). “Aging process in the subcortical auditory system,” in The Oxford Handbook of the Auditory Brainstem, ed.KandlerK. (Oxford: Oxford Press), 145. 10.1093/oxfordhb/9780190849061.013.16

  • 12

    CasparyD. M.SchattemanT. A.HughesL. F. (2005). Age-related changes in the inhibitory response properties of dorsal cochlear nucleus output neurons: Role of inhibitory inputs.J. Neurosci.251095210959.

  • 13

    ChenX.DuY.ChenL. (2019). Neuropeptides exert neuroprotective effects in Alzheimer’s Disease.Front. Mol. Neurosci.11:493. 10.3389/fnmol.2018.00493

  • 14

    ChumakT.RüttigerL.LeeS. C.CampanelliD.ZuccottiA.SingerW.et al (2016). BDNF in lower brain parts modifies auditory fiber activity to gain fidelity but increases the risk for generation of central noise after injury.Mol. Neurobiol.5356075627. 10.1007/s12035-015-9474-x

  • 15

    DeanC.LiuH.DunningF.ChangP.JacksonM.ChapmanE. (2009). Synaptotagmin-IV modulates synaptic function and long-term potentiation by regulating BDNF release.Nat. Neurosci.12767776.

  • 16

    DieniS.MatsumotoT.DekkersM.RauskolbS.IonescuM. S.DeograciasR.et al (2012). BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons.J. Cell Biol.196775788. 10.1083/jcb.201201038

  • 17

    EdwardsR. H. (1998). Neurotransmitter release: Variations on a theme.Curr. Biol.8R883R885. 10.1016/s0960-9822(07)00551-9

  • 18

    FaderS. M.ImaizumiK.YanagawaY.LeeC. C. (2016). Wisteria floribunda agglutinin-labeled perineuronal nets in the mouse inferior colliculus, thalamic reticular nucleus and auditory cortex.Brain Sci6:13. 10.3390/brainsci6020013

  • 19

    FrisinaR. D. (2001). Subcortical neural coding mechanisms for auditory temporal processing.Hear. Res.158127.

  • 20

    GomanA. M.LinF. R. (2016). Prevalence of hearing loss by severity in the United States.Am. J. Public Health10618201822. 10.2105/AJPH.2016.303299

  • 21

    GoyerD.SilveiraM. A.GeorgeA. P.BeebeN. L.EdelbrockR. M.MalinskiP. T.et al (2019). A novel class of inferior colliculus principal neurons labeled in vasoactive intestinal peptide-Cre mice.eLife8:e43770. 10.7554/eLife.43770

  • 22

    HafidiA.MooreT.SanesD. H. (1996). Regional distribution of neurotrophin receptors in the developing auditory brainstem.J. Comp. Neurol.367454464.

  • 23

    HallI. C.SellG. L.ChesterE. M.HurleyL. M. (2012). Stress-evoked increases in serotonin in the auditory midbrain do not directly result from elevations in serum corticosterone.Behav. Brain Res.2264149. 10.1016/j.bbr.2011.08.042

  • 24

    HelfertR. H.SommerT. J.MeeksJ.HofstetterP.HughesL. F. (1999). Age-related synaptic changes in the central nucleus of the inferior colliculus of Fischer-344 rats.J. Comp. Neurol.406285298.

  • 25

    HökfeltT. (2010). Looking at neurotransmitters in the microscope.Prog. Neurobiol.90101118. 10.1016/j.pneurobio.2009.10.005

  • 26

    HurleyL. M.PollakG. D. (1999). Serotonin differentially modulates responses to tones and frequency-modulated sweeps in the inferior colliculus.J. Neurosci.1980718082. 10.1523/JNEUROSCI.19-18-08071.1999

  • 27

    HurleyL. M.PollakG. D. (2001). Serotonin effects on frequency tuning of inferior colliculus neurons.J. Neurophysiol.85828842. 10.1152/jn.2001.85.2.828

  • 28

    HurleyL. M.PollakG. D. (2005a). Serotonin shifts first-spike latencies of inferior colliculus neurons.J. Neurosci.2578767886. 10.1523/JNEUROSCI.1178-05.2005

  • 29

    HurleyL. M.PollakG. D. (2005b). Serotonin modulates responses to species-specific vocalizations in the inferior colliculus.J. Comp. Physiol. A Neuroethol. Sens. Neural Behav. Physiol.191535546. 10.1007/s00359-005-0623-y

  • 30

    HurleyL. M.SullivanM. R. (2012). From behavioral context to receptors: Serotonergic modulatory pathways in the IC.Front. Neural Circ.6:58. 10.3389/fncir.2012.00058

  • 31

    HurleyL. M.ThompsonA. M.PollakG. D. (2002). Serotonin in the inferior colliculus.Hear. Res.168111. 10.1016/s0378-5955(02)00365-9

  • 32

    JonesE. G.RockelA. J. (1973). Observations on complex vesicles, neurofilamentous hyperplasia and increased electron density during terminal degeneration in the inferior colliculus.J. Comp. Neurol.14793118. 10.1002/cne.901470105

  • 33

    KeithleyE. M.RyanA. F.FeldmanM. L. (1992). Cochlear degeneration in aged rats of four strains.Hear. Res.59171178.

  • 34

    KennedyM. J.EhlersM. D. (2011). Mechanisms and function of dendritic exocytosis.Neuron69856875. 10.1016/j.neuron.2011.02.032

  • 35

    KimH.KimJ.LeeH.ShinE.KangH.JeonJ.et al (2021). Baiap3 regulates depressive behaviors in mice via attenuating dense core vesicle trafficking in subsets of prefrontal cortex neurons.Neurobiol. Stress16:100423. 10.1016/j.ynstr.2021.100423

  • 36

    KlepperA.HerbertH. (1991). Distribution and origin of noradrenergic and serotonergic fibers in the cochlear nucleus and inferior colliculus of the rat.Brain Res.557190201.

  • 37

    KnipperM.SingerW.SchwabeK.HagbergG. E.Li HegnerY.RüttigerL.et al (2022). Disturbed balance of inhibitory signaling links hearing loss and cognition.Front. Neural Circ.15:785603. 10.3389/fncir.2021.785603

  • 38

    KoehlerC. C.AlmassriL. S.TokarN.MafiA. M.O’HaraM. J.YoungJ. W.et al (2023). Age-related changes of GAD1 mRNA expression in the central inferior colliculus.Transl. Med. Aging702032

  • 39

    KommajosyulaS. P.BartlettE. L.CaiR.LingL.CasparyD. M. (2021). Corticothalamic projections deliver enhanced responses to medial geniculate body as a function of the temporal reliability of the stimulus.J. Physiol.59954655484. 10.1113/JP282321

  • 40

    LiS.LuY.DingD.MaZ.XingX.HuaX.et al (2020). Fibroblast growth factor 2 contributes to the effect of salidroside on dendritic and synaptic plasticity after cerebral ischemia/reperfusion injury.Aging121095110968. 10.18632/aging.103308

  • 41

    LinZ.LiY.HangY.WangC.LiuB.LiJ.et al (2022). Tuning the size of large dense-core vesicles and quantal neurotransmitter release via secretogranin II liquid-liquid phase separation.Adv. Sci.9:e2202263. 10.1002/advs.202202263

  • 42

    LipkaJ.KapiteinL. C.JaworskiJ.HoogenraadC. C. (2016). Microtubule-binding protein doublecortin-like kinase 1 (DCLK1) guides kinesin-3-mediated cargo transport to dendrites.EMBO J.35302318. 10.15252/embj.201592929

  • 43

    LipmanR. D. (1997). Pathobiology of aging rodents: Inbred and hybrid models.Exp. Gerontol.32215228. 10.1016/s0531-5565(96)00037-x

  • 44

    LipmanR. D.ChrispC. E.HazzardD. G.BronsonR. T. (1996). Pathologic characterization of brown Norway, brown Norway Fischer 344, and Fischer 344 brown Norway rats with relation to age.J. Gerontol. A Biol. Sci. Med. Sci.51B54B59.

  • 45

    MafiA.TokarN.RussM.BaratO.MellottJ. (2022). Age-related ultrastructural changes in the lateral cortex of the inferior colliculus.Neurobiol. Aging1204359.

  • 46

    MafiA. M.HoferL. N.RussM. G.YoungJ. W.MellottJ. G. (2020). The density of perineuronal nets increases with age in the inferior colliculus in the Fischer Brown Norway rat.Front. Aging Neurosci.11:27. 10.3389/fnagi.2020.00027

  • 47

    MafiA. M.RussM. G.HoferL. N.PhamV. Q.YoungJ. W.MellottJ. G. (2021). Inferior collicular cells that project to the auditory thalamus are increasingly surrounded by perineuronal nets with age.Neurobiol. Aging105115. 10.1016/j.neurobiolaging.2021.04.001

  • 48

    MalmiercaM. S.IzquierdoM. A.CristaudoS.HernándezO.Pérez-GonzálezD.CoveyE.et al (2008). A discontinuous tonotopic organization in the inferior colliculus of the rat.J. Neurosci.2847674776. 10.1523/JNEUROSCI.0238-08.2008

  • 49

    MastronardeD. (2003). SerialEM: A program for automated tilt series acquisition on tecnai microscopes using prediction of specimen position.Microsc. Microanal.911821183. 10.1017/S1431927603445911

  • 50

    MatsudaN.LuH.FukataY.NoritakeJ.GaoH.MukherjeeS.et al (2009). Differential activity-dependent secretion of brain-derived neurotrophic factor from axon and dendrite.J. Neurosci.291418514198.

  • 51

    MellottJ. G.BickfordM. E.SchofieldB. R. (2014). Descending projections from auditory cortex to excitatory and inhibitory cells in the nucleus of the brachium of the inferior colliculus.Front. Syst. Neurosci.8:188. 10.3389/fnsys.2014.00188

  • 52

    MeltserI.CanlonB. (2010). The expression of mitogen-activated protein kinases and brain-derived neurotrophic factor in inferior colliculi after acoustic trauma.Neurobiol. Disease40325330. 10.1016/j.nbd.2010.06.006

  • 53

    MerchánM.AguilarL. A.Lopez-PovedaE. A.MalmiercaM. S. (2005). The inferior colliculus of the rat: Quantitative immunocytochemical study of GABA and glycine.Neuroscience136907925.

  • 54

    MerighiA. (2018). Costorage of high molecular weight neurotransmitters in large dense core vesicles of mammalian neurons.Front. Cell. Neurosci.12:272. 10.3389/fncel.2018.00272

  • 55

    MichaelD. J.CaiH.XiongW.OuyangJ.ChowR. H. (2006). Mechanisms of peptide hormone secretion.Trends Endocrinol. Metab.17408415.

  • 56

    MottsS. D.SchofieldB. R. (2009). Sources of cholinergic input to the inferior colliculus.Neuroscience160103114.

  • 57

    NakamotoK. T.MellottJ. G.KilliusJ.Storey-WorkleyM. E.SowickC. S.SchofieldB. R. (2013). Analysis of excitatory synapses in the guinea pig inferior colliculus: A study using electron microscopy and GABA immunocytochemistry.Neuroscience237170183. 10.1016/j.neuroscience.2013.01.061

  • 58

    NakamotoK. T.MellottJ. G.KilliusJ.Storey-WorkleyM. E.SowickC. S.SchofieldB. R. (2014). Ultrastructural characterization of GABAergic and excitatory synapses in the inferior colliculus.Front. Neuroanat.8:108. 10.3389/fnana.2014.00108

  • 59

    NoftzW. A.BeebeN. L.MellottJ. G.SchofieldB. R. (2020). Cholinergic projections from the pedunculopontine tegmental nucleus contact excitatory and inhibitory neurons in the inferior colliculus.Front. Neural Circ.14:43. 10.3389/fncir.2020.00043

  • 60

    NoftzW. A.BeebeN. L.MellottJ. G.SchofieldB. R. (2021). Dense cholinergic projections to auditory and multisensory nuclei of the intercollicular midbrain.Hear. Res.411:108352. 10.1016/j.heares.2021.108352

  • 61

    NorenaA. J. (2011). An integrative model of tinnitus based on a central gain controlling neural sensitivity.Neurosci. Biobehav. Rev.3510891109.

  • 62

    OliverD. L. (2005). “Neuronal organization in the inferior colliculus,” in The Inferior Colliculus, edsWinerJ.SchreinerC. (New York, NY: Springer), 69114.

  • 63

    OliverD. L.MorestD. K. (1984). The central nucleus of the inferior colliculus in the cat.J. Comp. Neurol.222237264. 10.1002/cne.902220207

  • 64

    PainS.BrotS.GaillardA. (2022). Neuroprotective effects of neuropeptide Y against neurodegenerative disease.Curr. Neuropharmacol.2017171725. 10.2174/1570159X19666210906120302

  • 65

    PaloffA. M.UsunoffK. G. (1992). The fine structure of the inferior colliculus in the cat II. synaptic organization.J. Hirnforsch.3377106.

  • 66

    PaloffA. M.UsunoffK. G. (2000). Tyrosine hydroxylase-like immunoreactive synaptic boutons in the inferior colliculus of the cat.Ann. Anat.182423426. 10.1016/S0940-9602(00)80047-3

  • 67

    PaloffA. M.UsunoffK. G.Hinova-PalovaD. V.IvanovD. P. (1989). The fine structure of the inferior colliculus in the cat. I. Neuronal perikarya in the central nucleus.J. Hirnforschung306990.

  • 68

    PalombiP. S.CasparyD. M. (1996). GABA inputs control discharge rate primarily within frequency receptive fields of inferior colliculus neurons.J. Neurophysiol.7522112219. 10.1152/jn.1996.75.6.2211

  • 69

    ParthasarathyA.BartlettE. L. (2011). Age-related auditory deficits in temporal processing in F-344 rats.Neuroscience192619630. 10.1016/j.neuroscience.2011.06.042

  • 70

    ParthasarathyA.HerrmannB.BartlettE. L. (2018). Aging alters envelope representations of speech-like sounds in the inferior colliculus.Neurobiol. Aging733040.

  • 71

    PaxinosG.WatsonC. (1998). The Rat Brain in Stereotaxic Coordinates.San Diego, CA: Academic Press.

  • 72

    PelletierG.SteinbuschH. W.VerhofstadA. A. (1981). Immunoreactive substance P and serotonin present in the same dense-core vesicles.Nature2937172. 10.1038/293071a0

  • 73

    PersoonC. M.MoroA.NassalJ. P.FarinaM.BroekeJ. H.AroraS.et al (2018). Pool size estimations for dense-core vesicles in mammalian CNS neurons.EMBO J.37:e99672. 10.15252/embj.201899672

  • 74

    PetersA.PalayS. L.WebsterH. (1991). in The Fine Structure of the Nervous System: Neurons and Their Supporting Cells, ed.PalayS. (Oxford: Oxford University Press).

  • 75

    R Core Team (2020). R: A Language and Environment for Statistical Computing.Vienna: R Foundation for Statistical Computing.

  • 76

    RamamoorthyP.WangQ.WhimM. D. (2011). Cell type-dependent trafficking of neuropeptide Y-containing dense core granules in CNS neurons.J. Neurosci.311478314788. 10.1523/JNEUROSCI.2933-11.2011

  • 77

    RegehrW. G.CareyM. R.BestA. R. (2009). Activity-dependent regulation of synapses by retrograde messengers.Neuron63154170.

  • 78

    ReynoldsE. (1963). The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.J. Cell Biol.17208212.

  • 79

    RibakC. E.RobertsR. C. (1986). The ultrastructure of the central nucleus of the inferior colliculus of the Sprague-Dawley rat.J. Neurocytol.15421438. 10.1007/BF01611726

  • 80

    RichardsonB. D.BrozoskiT. J.LingL. L.CasparyD. M. (2012). Targeting inhibitory neurotransmission in tinnitus.Brain Res.14857787.

  • 81

    RobertsR. C.RibakC. E. (1987). An electron microscopic study of GABAergic neurons and terminals in the central nucleus of the inferior colliculus of the rat.J. Neurocytol.16333345. 10.1007/BF01611345

  • 82

    RobinsonL. C.BaratO.MellottJ. G. (2019). GABAergic and glutamatergic cells in the inferior colliculus dynamically express the GABAAR γ1 subunit during aging.Neurobiol. Aging8099110. 10.1016/j.neurobiolaging.2019.04.007

  • 83

    RockelA.JonesE. (1973). Observations on the fine structure of the central nucleus of the inferior colliculus of the cat.J. Comp. Neurol.1476192.

  • 84

    RumschlagJ. A.McClaskeyC. M.DiasJ. W.KerouacL. B.NobleK. V.PanganibanC.et al (2022). Age-related central gain with degraded neural synchrony in the auditory brainstem of mice and humans.Neurobiol. Aging1155059. 10.1016/j.neurobiolaging.2022.03.014

  • 85

    SatoT.WilsonT. S.HughesL. F.KonradH. R.NakayamaM.HelfertR. H. (2001). Age-related changes in levels of tyrosine kinase B receptor and fibroblast growth factor receptor 2 in the rat inferior colliculus: Implications for neural senescence.Neuroscience103695702. 10.1016/s0306-4522(01)00022-7

  • 86

    SchneiderC.RasbandW.EliceiriK. (2012). NIH Image to ImageJ: 25 years of image analysis.Nat. Methods9671675. 10.1038/nmeth.2089

  • 87

    SchofieldB. R.HurleyL. (2018). “Circuits for modulation of auditory function,” in The Mammalian Auditory Pathways Springer Handbook of Auditory Research, edsOliverD. L.CantN. B.FayR. R.PopperA. N. (Cham: Springer International Publishing), 235267.

  • 88

    SharmaV.NagT. C.WadhwaS.RoyT. S. (2009). Temporal distribution of mRNA expression levels of various genes in the developing human inferior colliculus.Neurosci. Lett.461229234. 10.1016/j.neulet.2009.06.049

  • 89

    ShimH. J.LeeL. H.HuhY.LeeS. Y.YeoS. G. (2012). Age-related changes in the expression of NMDA, serotonin, and GAD in the central auditory system of the rat.Acta Oto-laryngol.1324450. 10.3109/00016489.2011.622785

  • 90

    SilveiraM. A.AnairJ. D.BeebeN. L.MirjaliliP.SchofieldB. R.RobertsM. T. (2020). Neuropeptide Y expression defines a novel class of GABAergic projection neuron in the inferior colliculus.J. Neurosci.4046854699. 10.1523/JNEUROSCI.0420-20.2020

  • 91

    SilveiraM. A.DrotosA. C.PirroneT. M.VersalleT. S.BockA.RobertsM. T. (2023). Neuropeptide Y signaling regulates recurrent excitation in the auditory midbrain.J. Neurosci.4376267641. 10.1523/JNEUROSCI.0900-23.2023

  • 92

    SingerW.Panford-WalshR.KnipperM. (2014). The function of BDNF in the adult auditory system.Neuropharmacology76(Pt C), 719728. 10.1016/j.neuropharm.2013.05.008

  • 93

    SorraK. E.MishraA.KirovS. A.HarrisK. M. (2006). Dense core vesicles resemble active-zone transport vesicles and are diminished following synaptogenesis in mature hippocampal slices.Neuroscience14120972106. 10.1016/j.neuroscience.2006.05.033

  • 94

    SubiranaI.SanzH.VilaJ. (2014). Building bivariate tables: The compareGroups Package for R.J. Stat. Softw.57116. 10.18637/jss.v057.i12

  • 95

    SykaJ. (2020). “Age-related changes in the auditory brainstem and inferior colliculus,” in Aging and Hearing, edsHelferK. S.BartlettE. L.PopperA. N.FayR. R. (Switzerland: Springer), 6796.

  • 96

    TadrosS. F.D’SouzaM.ZettelM. L.ZhuX.Lynch-ErhardtM.FrisinaR. D. (2007). Serotonin 2B receptor: Upregulated with age and hearing loss in mouse auditory system.Neurobiol. Aging2811121123. 10.1016/j.neurobiolaging.2006.05.021

  • 97

    TaoC. L.LiuY. T.ZhouZ. H.LauP. M.BiG. Q. (2018). Accumulation of dense core vesicles in hippocampal synapses following chronic inactivity.Front. Neuroanat.12:48. 10.3389/fnana.2018.00048

  • 98

    TruetaC.De-MiguelF. F. (2012). Extrasynaptic exocytosis and its mechanisms: A source of molecules mediating volume transmission in the nervous system.Front. Physiol.3:319. 10.3389/fphys.2012.00319

  • 99

    WaltonJ. P.FrisinaR. D.O’NeillW. E. (1998). Age-related alteration in processing of temporal sound features in the auditory midbrain of the CBA mouse.J. Neurosci.1827642776.

  • 100

    WaltonJ. P.SimonH.FrisinaR. D. (2002). Age-related alterations in the neural coding of envelope periodicities.J. Neurophysiol.88565578. 10.1152/jn.2002.88.2.565

  • 101

    WenstrupJ. J. (2005). “The tectothalamic system,” in The Inferior Colliculus, edsWinerJ. A.SchreinerC. E. (New York, NY: Springer), 200230. 10.1007/0-387-27083-3_7

  • 102

    WisselK.WefstaedtP.MillerJ. M.LenarzT.StöverT. (2006). Differential brain-derived neurotrophic factor and transforming growth factor-beta expression in the rat cochlea following deafness.Neuroreport1712971301. 10.1097/01.wnr.0000233088.92839.23

  • 103

    XiaX.LessmannV.MartinT. F. (2009). Imaging of evoked dense-core-vesicle exocytosis in hippocampal neurons reveals long latencies and kiss and- run fusion events.J. Cell Sci.1227582.

  • 104

    YiM.LiH.WuZ.YanJ.LiuQ.OuC.et al (2018). A promising therapeutic target for metabolic diseases: Neuropeptide Y receptors in humans.Cell Physiol. Biochem.188107. 10.1159/000486225

  • 105

    ZhengY.WildongerJ.YeB.ZhangY.KitaA.YoungerS. H.et al (2008). Dynein is required for polarized dendritic transport and uniform microtubule orientation in axons.Nat. Cell Biol.1011721180. 10.1038/ncb1777

Summary

Keywords

inferior colliculus, GABA, synapse, aging, dense core vesicles

Citation

Mellott JG, Duncan S, Busby J, Almassri LS, Wawrzyniak A, Iafrate MC, Ohl AP, Slabinski EA, Beaver AM, Albaba D, Vega B, Mafi AM, Buerke M, Tokar NJ and Young JW (2024) Age-related upregulation of dense core vesicles in the central inferior colliculus. Front. Cell. Neurosci. 18:1396387. doi: 10.3389/fncel.2024.1396387

Received

05 March 2024

Accepted

11 April 2024

Published

01 May 2024

Volume

18 - 2024

Edited by

Christian Keine, University of Oldenburg, Germany

Reviewed by

Tara Sankar Roy, North DMC Medical College and Hindu Rao Hospital, India

Aaron Benson Wong, Erasmus University Medical Center, Netherlands

Updates

Copyright

*Correspondence: Jeffrey G. Mellott,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics